Hyperglycemia Management in the Hospital: About Glucose Targets and Process Improvements

References

• Cook CB, Castro JC, Schmidt RE, et al. Diabetes care in hospitalized noncritically ill patients: More evidence for clinical inertia and negative therapeutic momentum. J Hosp Med. 2007; 2(4): 203–211.
   PubMed Web of Science ®Google Scholar
• Clement S, Braithwaite SS, Magee MF, et al. American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004; 27(2): 553–591.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002; 87(3): 978–982.
   PubMed Web of Science ®Google Scholar
• Beilman GJ, Joseph JI. Practical considerations for glucose control in hospitalized patients. Diabetes Technol Ther. 2005; 7(5): 823–830.
   Google Scholar
• Conner TM, Flesner-Gurley KR, Barner JC. Hyperglycemia in the hospital setting: the case for improved control among non-diabetics. Ann Pharmacother. 2005; 39(3): 492–501.
   Google Scholar
• Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354(5): 449–461.
   PubMed Web of Science ®Google Scholar
• Garber AJ, Moghissi ES, Bransome ED Jr, et al. American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004; 10(1): 77–82.
   PubMedGoogle Scholar
• Langley J, Adams G. Insulin-based regimens decrease mortality rates in critically ill patients: a systematic review. Diabetes Metab Res Rev. 2007; 23(3): 184–192.
   PubMed Web of Science ®Google Scholar
• Pomposelli JJ, Baxter JK 3rd, Babineau TJ, et al. Early postoperative glucose control predicts nosocomial infection rate in diabetic patients. JPEN J Parenter Enteral Nutr. 1998; 22(2): 77–81.
   PubMed Web of Science ®Google Scholar
• Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann ThoracSurg. 1997; 63(2): 356–361.
   PubMed Web of Science ®Google Scholar
• Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003; 78(12): 1471–1478.
   PubMed Web of Science ®Google Scholar
• Baker EH, Janaway CH, Philips BJ, et al. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006; 61 (4): 284–289.
   PubMed Web of Science ®Google Scholar
• Rady MY, Johnson DJ, Patel BM, Larson JS, Helmers RA. Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. Mayo Clin Proc. 2005; 80(12): 1558–1567.
   Google Scholar
• Levetan CS. Effect of hyperglycemia on stroke outcomes. Endocr Pract. 2004; 10(Suppl 2): 34 39.
   Google Scholar
• Saint S, Kaufman SR, Rogers MA, Baker PD, Boyko EJ, Lipsky BA. Risk factors for nosocomial urinary tract-related bacteremia: a case- control study. Am J Infect Control. 2006; 34(7): 401–407.
   Google Scholar
• Lepore G, Maglio ML, Cuni C, et al. Poor glucose control in the year before admission as a powerful predictor of amputation in hospitalized patients with diabetic foot ulceration. Diabetes Care. 2006; 29(8): 1985.
   Google Scholar
• Wahab NN, Cowden EA, Pearce N J, Gardner MJ, Merry H, Cox JL. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002; 40(10): 1748–1754.
   PubMed Web of Science ®Google Scholar
• Ainla T, Baburin A, Teesalu R, Rahu M. The association between hyperglycaemia on admission and 180-day mortality in acute myocardial infarction patients with and without diabetes. Diabet Med. 2005; 22(10): 1321–1325.
   Google Scholar
• Gale SC, Sicoutris C, Reilly PM, Schwab CW, Gracias VH. Poor glycemic. control is associated with increased mortality in critically ill trauma patients. Am Surg. 2007; 73(5): 454–460.
   PubMed Web of Science ®Google Scholar
• Pittas AG, Siegel RD, Lau J. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. Arch Intern Med. 2004; 164(18): 2005–2011.
   PubMedGoogle Scholar
• Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345(19): 1359–1367.
   PubMed Web of Science ®Google Scholar
• Hein MD. Management of hyperglycemia in the hospitalized podiatric medical patient. J Am Podiatr Med Assoc. 2004; 94(2): 135–148.
   Google Scholar
• Garber AJ. New standards to reduce morbidity and mortality in hospitalized patients with diabetes. Am Fam Physician. 2006; 73(4): 591–594.
   Google Scholar
• Ahmann AJ. Inpatient management of hospitalized patients with type 2 diabetes. Curr Diab Rep. 2004; 4(5): 346–351.
   Google Scholar
• Newton CA, Young S. Financial implications of glycemic control: results of an inpatient diabetes management program. Endocr Pract. 2006; 12(suppl 3): 43^t8.
   Google Scholar
• Olson L, Muchmore J, Lawrence CB. The benefits of inpatient diabetes care: improving quality of care and the bottom line. Endocr Pract. 2006; 12(suppl 3): 35–42.
   PubMedGoogle Scholar
• Furnary AP, Wu Y, Bookin SO. Effect of hyperglycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract. 2004; 10(suppl 2): 21–33.
   PubMedGoogle Scholar
• Van den Berghe G, Wouters PJ, Kesteloot K, Hilleman DE. Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patients. Crit Care Med. 2006; 34(3): 612–616.
   PubMed Web of Science ®Google Scholar
• Krinsley JS, Jones RL. Cost analysis of intensive glycemic control in critically ill adult patients. Chest. 2006; 129(3): 644–650.
   PubMed Web of Science ®Google Scholar
• Cohen MR, Kilo CM. In: Cohen MR, ed. Medication Errors. Washington, DC: American Pharmaceutical Association; 1999.
   Google Scholar
• Joint Commission. Inpatient diabetes certification. http://www.jointcommission.org/CertificationPrograms/Inpatient+Diabetes. Accessed August 25,2008.
   Google Scholar
• Markovitz LJ, Wiechmann RJ, Harris N, et al. Description and evaluation of a glycemic management protocol for patients with diabetes undergoing heart surgery. Endocr Pract. 2002; 8(1): 10–18.
   PubMedGoogle Scholar
• McDonough KA, DeWitt DE. Inpatient management of diabetes. Prim Care. 2003; 30(3): 557–567.
   Google Scholar
• Moghissi E. Hospital management of diabetes: beyond the sliding scale. Cleve Clin J Med. 2004; 71(10): 801–808.
   Google Scholar
• Moghissi ES, Hirsch IB. Hospital management of diabetes. Endocrinol Metab Clin North Am. 2005; 34(1): 99–116.
   Google Scholar
• Trence DL, Kelly JL, Hirsch IB. The rationale and management of hyperglycemia for in-patients with cardiovascular disease: time for change. J Clin Endocrinol Metab. 2003; 88(6): 2430–2437.
   Google Scholar
• Leahy JL. Insulin management of diabetic patients on general medical and surgical floors. Endocr Pract. 2006; 12(suppl 3): 86–90.
   Google Scholar
• Goldberg PA, Siegel MD, Sherwin RS, et al. Implementation of a safe and effective insulin infusion protocol in a medical intensive care unit. Diabetes Care. 2004; 27(2): 461 467.
   PubMed Web of Science ®Google Scholar
• Eigsti J, Henke K. Innovative solutions: development and implementation of a tight blood glucose management protocol: one community hospital's experience. Dimens Crit Care Nurs. 2006; 25(2): 62 65.
   Google Scholar
• DeSantis AJ, Schmeltz LR, Schmidt K, et al. Inpatient management of hyperglycemia: the Northwestern experience. Endocr Pract. 2006; 12(5): 491–505.
   PubMedGoogle Scholar
• Beishuizen A, Groeneveld AB. Implementing strict glucose control: it is not that simple… Crit Care Med. 2006; 34(12): 3050–3051.
   Google Scholar
• Clayton SB, Mazur JE, Condren S, Hermayer KL, Strange C. Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit. Crit Care Med. 2006; 34(12): 2974–2978.
   Google Scholar
• Devos P, Preiser JC. Current controversies around tight glucose control in critically ill patients. Curr Opin Clin Nutr Metab Care. 2007; 10(2): 206–209.
   Google Scholar
• Freire AX, Avecillas JF, Yataco JC, Freire NE. Hypoglycemia risk: a cause for concern in the intensive care unit hyperglycemia control debate. Crit Care Med. 2007; 35(4): 1222.
   Google Scholar
• Thomas AN, Boxall EM, Twamley HW. Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med. 2007; 35(4): 1218–1219.
   Google Scholar
• Ligtenberg JJ, Stemerdink A, Vogelzang M, Borggreve HF, Herngreen T, Zijlstra JG. Tight glucose control and hypoglycemia: should we bother? Crit Care Med. 2007; 35(4): 1218.
   Google Scholar
• Preiser JC, Devos P. Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med. 2007; 35(9 Suppl): S503–S507.
   Google Scholar
• Gilman JA. A quality improvement project for better glycemic control in hospitalized patients with diabetes. Diabetes Educ. 2001; 27(4): 541–546.
   Google Scholar
• Braithwaite SS, Buie MM, Thompson CL, et al. Hospital hypoglycemia: not only treatment but also prevention. Endocr Pract. 2004; 10(suppl 2): 89–99.
   Google Scholar
• Bode BW, Braithwaite SS, Steed RD, Davidson PC. Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy. Endocr Pract. 2004; 10(Suppl 2): 71–80.
   Google Scholar
• Hermansen K, Fontaine P, Kukolja KK, Peterkova V, Leth G, Gall MA. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes. Diabetologia. 2004; 47(4): 622–629.
   PubMed Web of Science ®Google Scholar
• Vazquez-Carrera M, Silvestre JS. Insulin analogues in the management of diabetes. Methods Find Exp Clin Pharmacol. 2004; 26(6): 445–461.
   Google Scholar
• Rosenstock J, Dailey G, Massi-Benedetti M, Fritsche A, Lin Z, Salzman A. Reduced hypoglycemia risk with insulin glargine: a metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes. Diabetes Care. 2005; 28(4): 950–955.
   PubMed Web of Science ®Google Scholar
• Home P, Kurtzhals P. Insulin detemir: from concept to clinical experience. Expert Opin Pharmacother. 2006; 7(3): 325–343.
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Smiley D, Zisman A, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007; 30(9): 2181–2186.
   PubMed Web of Science ®Google Scholar
• Finney SJ, Zekveld C, Elia A, Evans TW. Glucose control and mortality in critically ill patients. JAMA. 2003; 290(15): 2041–2047.
   PubMed Web of Science ®Google Scholar
• Haas LB. Optimizing insulin use in type 2 diabetes: role of basal and prandial insulin in long-term care facilities. J Am Med Directors Assoc. 2007; 8(8): 502–510.
   Google Scholar
• Juneja R, Roudebush C, Kumar N, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007; 9(3): 232–240.
   PubMedGoogle Scholar
• Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004; 56(5): 1058–1062.
   Google Scholar
• Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355(9206): 773–778.
   PubMed Web of Science ®Google Scholar
• Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001; 32(10): 2426–2432.
   PubMed Web of Science ®Google Scholar
• Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of Type II diabetes. Diabetologia. 2002; 45(7): S13–S17.
   Web of Science ®Google Scholar
• Meece J. Pharmacoeconomic advantages of insulin analogs. US Pharm. 2006; 31: HS42–HS50.
   Google Scholar
• Brunton SA. Nocturnal hypoglycemia: answering the challenge with long-acting insulin analogs. MedGenMed. 2007; 9(2): 38.
   Google Scholar
• Peterson GE. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir. Curr Med Res Opin. 2006; 22(12): 2613–2619.
   PubMed Web of Science ®Google Scholar
• Valensi P, Cosson E. Is insulin detemir able to favor a lower variability in the action of injected insulin in diabetic subjects? Diabetes Metabolism. 2005; 31(4 pt 2): 4S34–4S39.
   Google Scholar
• Boyle PJ, Zrebiec J. Management of diabetes-related hypoglycemia. South Med J. 2007; 100(2): 183–194.
   Google Scholar
• Klein O, Lynge J, Endahl L, Damholt B, Nosek L, Heise T. Albumin-bound basal insulin analogues (insulin detemir and NN344): comparable time-action profiles but less variability than insulin glargine in type 2 diabetes. Diabetes Obes Metab. 2007; 9(3): 290–299.
   PubMed Web of Science ®Google Scholar
• NovoLog® (insulin aspart [rDNA origin] injection) [package insert]. Princeton, NJ: Novo Nordisk; March 14, 2008.
   Google Scholar
• Humalog® (insulin lispro injection [rDNA origin]) [package insert]. Indianapolis, IN: Eli Lilly and Company; September 6, 2007.
   Google Scholar
• Apidra® (insulin glulisine [rDNA origin] injection) [package insert], Bridgewater, NJ: sanofi-aventis U.S. LLC; April 2007.
   Google Scholar
• Nasraway SA Jr. Sitting on the horns of a dilemma: avoiding severe hypoglycemia while practicing tight glycemic control. Crit Care Med. 2007; 35(10): 2435–2437.
   Google Scholar
• Juneja R, Roudebush C, Kumar N, et al. Utilization of a computerized intravenous insulin infusion program to control blood glucose in the intensive care unit. Diabetes Technol Ther. 2007; 9(3): 232–240.
   PubMedGoogle Scholar
• Heatlie JM. Reducing insulin medication errors: evaluation of a quality improvement initiative. J Nurs Staff Dev. 2003; 19(2): 92–98.
   Google Scholar
• LaSalle JR. New insulin analogs: insulin detemir and insulin glulisine. Pract Diabetology. 2006; 25: 34–44.
   Google Scholar
• Kamal AD, Bain SC. Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analogues. Expert Opin Drug Safety. 2007; 6(1): 5–7.
   PubMed Web of Science ®Google Scholar
• Daugherty KK. Review of insulin therapy. J Pharm Pract. 2004; 17: 10–19.
   Google Scholar
• Heise T, Pieber TR. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies. Diabetes Obes Metab. 2007; 9(5): 648–659.
   PubMed Web of Science ®Google Scholar
• Abourizk NN, Vora CK, Verma PK. Inpatient diabetology. The new frontier. J Gen Intern Med. 2004; 19(5 pt 1): 466–471.
   PubMedGoogle Scholar
• Achtmeyer CE, Payne TH, Anawalt BD. Computer order entry system decreased use of sliding scale insulin regimens. Methods Inf Med. 2002; 41(4): 277–281.
   Google Scholar
• Schoeffler JM, Rice DA, Gresham DG. 70/30 insulin algorithm versus sliding scale insulin. Ann Pharmacother. 2005; 39(10): 1606–1610.
   Google Scholar
• Golightly LK, Jones MA, Hamamura DH, Stolpman NM, McDermott MT. Management of diabetes mellitus in hospitalized patients: efficiency and effectiveness of sliding-scale insulin therapy. Pharmacotherapy. 2006; 26(10): 1421–1432.
   PubMed Web of Science ®Google Scholar
• Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997; 157(5): 545–552.
   PubMedGoogle Scholar
• Donihi AC, DiNardo MM, Devita MA, Korytkowski MT. Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin. Qual Saf Health Care. 2006; 15(2): 89–91.
   PubMedGoogle Scholar
• Browning LA, Dumo P. Sliding-scale insulin: an antiquated approach to glycemic control in hospitalized patients. Am J Health Syst Pharm. 2004; 61(15): 1611–1614.
   PubMed Web of Science ®Google Scholar
• Ku SY, Sayre CA, Hirsch IB, Kelly JL. New insulin infusion protocol improves blood glucose control in hospitalized patients without increasing hypoglycemia. Jt CommJQual Patient Saf. 2005; 31(3): 141–147.
   Google Scholar
• Hellman R. Patient safety and inpatient glycemic control: translating concepts into action. Endocr Pract. 2006; 12(suppl 3): 49–55.
   Google Scholar
• Santell JP, Hicks RW, McMeekin J, Cousins DD. Medication errors: experience of the United States Pharmacopeia (USP) MEDMARX reporting system. J Clin Pharmacol. 2003; 43(7): 760–767.
   PubMed Web of Science ®Google Scholar
• Lien LF, Spratt SE, Woods Z, Osborne KK, Feinglos MN. Optimizing hospital use of intravenous insulin therapy: improved management of hyperglycemia and error reduction with a new nomogram. Endocr Pract. 2005; 11(4): 240–253.
   Google Scholar
• Vigersky RA. Optimizing management of type 2 diabetes in hospitalized patients who are not critically ill. Diabetes Technol Ther. 2005; 7: 831–833.
   Google Scholar
• Wild D, von Maitzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L. A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Courts. 2007; 68(1): 10–15.
   PubMed Web of Science ®Google Scholar
• Greci LS, Kailasam M, Malkani S, et al. Utility of HbA1c levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care. 2003; 26(4): 1064–1068.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004; 109(3): 433–438.
   PubMed Web of Science ®Google Scholar
• Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther. 2005; 27(suppl B): S89–S100.
   PubMed Web of Science ®Google Scholar
• Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002; 26(suppl 3): S18–S24.
   PubMed Web of Science ®Google Scholar
• Austin MM, Haas L, Johnson T, et al. Self-monitoring of blood glucose: benefits and utilization. Diabetes Educ. 2006; 32(6): 835–837.
   Google Scholar
• Wheeler K, Crawford R, McAdams D, et al. Inpatient to outpatient transfer of care in urban patients with diabetes: patterns and determinants of immediate postdischarge follow-up. Arch Intern Med. 2004; 164(4): 447–453.
   Google Scholar